We show that the drug resistance of tumor cells of leukemia patients estimated in vitro at diagnosis correlates with a poor response to chemotherapy, usually combined with aberrant and immature immunological markers, cytogenetic abnormalities, and elevated MDR1 mRNA and P-gp expression. Here, PGP is linked to neoplasm.